TP53 and pulmonary arterial hypertension: Based on comprehensive data acquired through extensive animal studies, plasma metabolomics, transcriptome sequencing and cytological analysis, this study demonstrates that Cordycepin activates the P53–P21 signaling pathway, which plays a pivotal role in mitigating the progression of PAH.